[GOAL] Elsevier's interpretation of CC BY-NC-ND

Tue Jun 20 07:17:46 BST 2017

Dear Richard

Elsevier's hosting policy<https://www.elsevier.com/about/our-business/policies/hosting> explains how platforms can host Elsevier content. This includes enabling institutional repositories to share their employee's or student's accepted manuscripts publicly after an embargo period, but not beforehand.

The challenge with the proposal below is that it wouldn’t really work very well for very long; an embargo period is needed to enable the subscription model to continue to operate, in the absence of a separate business model.

Best wishes

Gemma

Gemma Hersh
VP, Policy and Communications
Elsevier I 125 London Wall I London I EC2Y 5AS
M: +44 (0) 7855 258 957 I E: g.hersh at elsevier.com<mailto:g.hersh at elsevier.com>
Twitter: @gemmahersh

From: goal-bounces at eprints.org [mailto:goal-bounces at eprints.org] On Behalf Of Richard Poynder
Sent: 18 June 2017 14:30
To: Global Open Access List (Successor of AmSci) <goal at eprints.org>
Subject: Re: [GOAL] Elsevier's interpretation of CC BY-NC-ND

*** External email: use caution ***

On a related topic, this poster might be of interest to list members:

Exploiting Elsevier’s Creative Commons License Requirement to Subvert Embargo

"In the last round of author sharing policy revisions, Elsevier created a labyrinthine title-by-title embargo structure requiring embargoes from 12-48 months for author sharing via institutional repository (IR), while permitting immediate sharing via author's personal website or blog. At the same time, all pre-publication versions are to bear a Creative Commons-Attribution-Noncommercial-No Derivatives (CC-BY-NC-ND) license.

"At the time this policy was announced, it was rightly criticized by many in the scholarly communication community as overly complicated and unnecessary. However, this CC licensing requirement creates an avenue for subverting the embargo in the IR to achieve quicker open distribution of the author's accepted manuscript.

"In short, authors may post an appropriately licensed copy on their personal site, at which point we may deposit without embargo in the IR, not through the license granted in the publication agreement, but through the CC license on the author's version, which the sharing policy mandates. This poster will outline this issue, our experimentation with application, and engage viewers in questions regarding its potential risks, benefits, and workflows."

https://kuscholarworks.ku.edu/handle/1808/24107

On 18 June 2017 at 12:24, Mittermaier, Bernhard <b.mittermaier at fz-juelich.de<mailto:b.mittermaier at fz-juelich.de>> wrote:
Dear colleagues,

on sharing in file-sharing networks, Creatice Commons explain:

“Can I share CC-licensed material on file-sharing networks?
Yes. All CC licenses allow redistribution of the unmodified material by any means, including distribution via file-sharing networks. Note that file-trading is expressly considered to be noncommercial for purposes of compliance with the NC licenses. Barter of NC-licensed material for other items of value is not permitted.”
https://creativecommons.org/faq/#can-i-share-cc-licensed-material-on-file-sharing-networks

The “Elsevier Sharing Rules” say
“CC-BY-NC-ND licensed articles may be shared on non-commercial platforms only.”
http://help.sciencedirect.com/flare/sdhelp_Left.htm#CSHID=password.htm|StartTopic=Content%2Fsharing_pubs.htm|SkinName=svs_SD<http://help.sciencedirect.com/flare/sdhelp_Left.htm#CSHID=password.htm%7CStartTopic=Content%2Fsharing_pubs.htm%7CSkinName=svs_SD>

and again in the table at the bottom of that webpage: “Public posting on commercial platforms (e.g., www.researchgate.net<http://www.researchgate.net>, www.academia.edu<http://www.academia.edu>)” :not allowed

I’ve been asking Alicia Wise, on what grounds why Elsevier takes that position. She replied:
„Both ResearchGate & academia.edu<http://academia.edu> use content commercially to sell advertising & services around the content they disseminate” and “Both ResearchGate & academia.edu<https://t.co/IQgdiiCF1s> are problems in Germany as they go beyond private use to make NC content publicly available” (https://twitter.com/wisealic/status/874284792275140609 and https://twitter.com/wisealic/status/874284916644696066 )

My interpretation of the CC licence is that sharing of CC BY-NC-ND article by commercial platforms is OK as long as they don’t sell the articles (which they don’t do).
But apart from that - what authors are doing is IMHO definitely not prohibited because they have no commercial gain whatsoever.

What do you think?

Kind regards
Bernhard
###########################################

Dr. Bernhard Mittermaier
Forschungszentrum Jülich GmbH
Leiter der Zentralbibliothek / Head of the Central Library
52425 Jülich
Tel  ++49-2461-613013<tel:+49%202461%20613013>
Fax ++49-2461-616103<tel:+49%202461%20616103>

Sitz der Gesellschaft: Juelich
Eingetragen im Handelsregister des Amtsgerichts Dueren Nr. HR B 3498
Vorsitzender des Aufsichtsrats: MinDir Dr. Karl Eugen Huthmacher
Geschaeftsfuehrung: Prof. Dr.-Ing. Wolfgang Marquardt (Vorsitzender),
Karsten Beneke (stellv. Vorsitzender), Prof. Dr.-Ing. Harald Bolt,
Prof. Dr. Sebastian M. Schmidt

_______________________________________________
GOAL mailing list
GOAL at eprints.org<mailto:GOAL at eprints.org>
http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal

--
Richard Poynder
www.richardpoynder.co.uk<http://www.richardpoynder.co.uk>

________________________________

Elsevier Limited. Registered Office: The Boulevard, Langford Lane, Kidlington, Oxford, OX5 1GB, United Kingdom, Registration No. 1982084, Registered in England and Wales.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: http://mailman.ecs.soton.ac.uk/pipermail/goal/attachments/20170620/2915b455/attachment-0001.html 